<?xml version="1.0" encoding="UTF-8"?>
<!DOCTYPE root>
<article xmlns:mml="http://www.w3.org/1998/Math/MathML" xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance" xmlns:ali="http://www.niso.org/schemas/ali/1.0/" article-type="research-article" dtd-version="1.2" xml:lang="en"><front><journal-meta><journal-id journal-id-type="publisher-id">Russian Journal of Immunology</journal-id><journal-title-group><journal-title xml:lang="en">Russian Journal of Immunology</journal-title><trans-title-group xml:lang="ru"><trans-title>Russian Journal of Immunology</trans-title></trans-title-group></journal-title-group><issn publication-format="print">1028-7221</issn><issn publication-format="electronic">2782-7291</issn><publisher><publisher-name xml:lang="en">Russian Society of Immunology</publisher-name></publisher></journal-meta><article-meta><article-id pub-id-type="publisher-id">138</article-id><article-id pub-id-type="doi">10.31857/S102872210006617-3</article-id><article-categories><subj-group subj-group-type="toc-heading" xml:lang="en"><subject>ORIGINAL ARTICLES</subject></subj-group><subj-group subj-group-type="toc-heading" xml:lang="ru"><subject>ОРИГИНАЛЬНЫЕ СТАТЬИ</subject></subj-group><subj-group subj-group-type="article-type"><subject>Research Article</subject></subj-group></article-categories><title-group><article-title xml:lang="en">CD4+ T-LYMPHOCYTE FUNCTION IS VIOLATED IN HIV-INFECTED PATIENTS WITH DISCORDANT RESPONSE TO ANTIRETROVIRAL THERAPY</article-title><trans-title-group xml:lang="ru"><trans-title>НАРУШЕНИЕ ФУНКЦИИ CD4+ Т-ЛИМФОЦИТОВ У ВИЧ-ИНФИЦИРОВАННЫХ ПАЦИЕНТОВ С ДИСКОРДАНТНЫМ ОТВЕТОМ НА АНТИРЕТРОВИРУСНУЮ ТЕРАПИЮ</trans-title></trans-title-group></title-group><contrib-group><contrib contrib-type="author"><name-alternatives><name xml:lang="en"><surname>Korolevskaya</surname><given-names>L. B.</given-names></name><name xml:lang="ru"><surname>Королевская</surname><given-names>Л. Б.</given-names></name></name-alternatives><address><country country="RU">Russian Federation</country></address><bio xml:lang="en"><p>PhD, research scientist of the Laboratory of Ecological Immunology,</p><p>Perm</p></bio><bio xml:lang="ru"><p>к. м. н., научный сотрудник лаборатории экологической иммунологии,</p><p>614081, г. Пермь, ул. Голева, д. 13</p></bio><email>bioqueen@mail.ru</email><xref ref-type="aff" rid="aff1"/></contrib><contrib contrib-type="author"><name-alternatives><name xml:lang="en"><surname>Saidakova</surname><given-names>E. V.</given-names></name><name xml:lang="ru"><surname>Сайдакова</surname><given-names>Е. В.</given-names></name></name-alternatives><address><country country="RU">Russian Federation</country></address><bio xml:lang="en"><p>PhD, junior research scientist of the Laboratory of Ecological Immunology,</p><p>Perm</p></bio><bio xml:lang="ru"><p>к. б. н., младший научный сотрудник лаборатории экологической иммунологии,</p><p>Пермь</p></bio><xref ref-type="aff" rid="aff1"/></contrib></contrib-group><aff-alternatives id="aff1"><aff><institution xml:lang="en">Institute of Ecology and Genetics of Microorganisms Ural Branch of the Russian Academy of Sciences</institution></aff><aff><institution xml:lang="ru">«Институт экологии и генетики микроорганизмов Уральского отделения Российской академии наук» – филиал ПФИЦ</institution></aff></aff-alternatives><pub-date date-type="pub" iso-8601-date="2019-04-15" publication-format="electronic"><day>15</day><month>04</month><year>2019</year></pub-date><volume>22</volume><issue>2-1</issue><issue-title xml:lang="en"/><issue-title xml:lang="ru"/><fpage>329</fpage><lpage>331</lpage><history><date date-type="received" iso-8601-date="2020-04-29"><day>29</day><month>04</month><year>2020</year></date><date date-type="accepted" iso-8601-date="2020-04-29"><day>29</day><month>04</month><year>2020</year></date></history><permissions><copyright-statement xml:lang="en">Copyright ©; 2019, Korolevskaya L.B., Saidakova E.V.</copyright-statement><copyright-statement xml:lang="ru">Copyright ©; 2019, Королевская Л.Б., Сайдакова Е.В.</copyright-statement><copyright-year>2019</copyright-year><copyright-holder xml:lang="en">Korolevskaya L.B., Saidakova E.V.</copyright-holder><copyright-holder xml:lang="ru">Королевская Л.Б., Сайдакова Е.В.</copyright-holder><ali:free_to_read xmlns:ali="http://www.niso.org/schemas/ali/1.0/"/><license><ali:license_ref xmlns:ali="http://www.niso.org/schemas/ali/1.0/">https://creativecommons.org/licenses/by/4.0</ali:license_ref></license></permissions><self-uri xlink:href="https://rusimmun.ru/jour/article/view/138">https://rusimmun.ru/jour/article/view/138</self-uri><abstract xml:lang="en"><p>In HIV-infected patients with a discordant response to antiretroviral therapy, CD4+ T-cell proliferative capacity, ability to synthesize IL-2, and resistance to apoptosis were accessed. It was shown that in those subjects, CD4+ T-cells are characterized by a decreased mitotic activity and IL-2 production; and an increased rate of programmed death. Disorders found could be the basis for the ineff ective CD4+ Tcell counts restoration in patients with a discordant response to the treatment.</p></abstract><trans-abstract xml:lang="ru"><p>Оценивали способность к пролиферации, синтезу ИЛ-2 и склонности к апоптозу CD4+ Т-лимфо цитов ВИЧ-инфицированных больных с дискордантным ответом на антиретровирусную терапию. Установлено снижение митотической активности и продукции ИЛ-2, усиление темпов гибели CD4+ Т-клеток периферической крови. Выявленные нарушения могут быть причиной неэффективного восстановления численности CD4+ Т-лимфоцитов у больных с дискордантным ответом на лечение.</p></trans-abstract><kwd-group xml:lang="en"><kwd>HIV infection</kwd><kwd>CD4+ T lymphocytes</kwd><kwd>antiretroviral therapy</kwd><kwd>discordant response</kwd><kwd>proliferation</kwd><kwd>interleukin-2</kwd><kwd>apoptosis</kwd></kwd-group><kwd-group xml:lang="ru"><kwd>ВИЧ-инфекция</kwd><kwd>CD4+ Т-лимфоциты</kwd><kwd>антиретровирусная терапия</kwd><kwd>дискордантный ответ</kwd><kwd>пролиферация</kwd><kwd>ИЛ-2</kwd><kwd>апоптоз</kwd></kwd-group><funding-group/></article-meta></front><body></body><back><ref-list><ref id="B1"><label>1.</label><mixed-citation>1. Autran B, Carcelaint G., Li T. S., Blanc C., Renaud M., Durali M., Mathez D., Calvez V., Leibowitch J., Katlama C., Debre P. Restoration of immune system with anti-retroviral therapy. Immunol. Lett. 1999, 66, 207–211.</mixed-citation></ref><ref id="B2"><label>2.</label><mixed-citation>2. Massanella M., Negredo E., Clotet B., Blanko J. Immunodiscordant responses to HAART – mechanisms and consequences/ Expert Rev/ Clin. Immunol. 2013, 9, 1135–1149.</mixed-citation></ref><ref id="B3"><label>3.</label><mixed-citation>3. Сайдакова Е. В., Шмагель К. В., Королевская Л. Б., Шмагель Н. Г., Гуляева Н. И., Фрейнд Г. Г., Южанинова С. В., Черешнев В. А. Пролиферация CD4+ Т-лим фо цитов пр развитии дискордантного ответа иммунной системы на антиретровирусную терапию у ВИЧ-ин фи ци ро ван ных больных. Цитология, 2018, 60(12), 1029–1036.</mixed-citation></ref><ref id="B4"><label>4.</label><mixed-citation>4. Bocharov G., Luzyanina T., Cupovic J., Ludewig B. Asymmetry of cell division in CFSE-based lymphocyte proliferation analysis. Front. Immunol. 2013, 4, 264.</mixed-citation></ref><ref id="B5"><label>5.</label><mixed-citation>5. Hansjee N., Kaufmann G. R., Strub C., Weber R., Battegay M., Erb P., and the Swiss HIV Cohort Study. Persistent apoptosis in HIV-1-infected individuals receiving potent antiretroviral therapy is associated with poor recovery of CD4 T lymphocytes. J. Acquir. Immune. Defic. Syndr, 2004, 36, 671–677.</mixed-citation></ref></ref-list></back></article>
